Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine.
about
A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphateTreatment of CMV retinitis in an AIDS patientActive cytomegalovirus particles in the eyes of an AIDS patient being treated with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (Ganciclovir)Treatment of cytomegalovirus retinitis with ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (BW B759U)Effect of antiviral agents on replication of herpes simplex virus type 1 in brain culturesChemotherapeuticsGenomic epidemiology of the Haitian cholera outbreak: a single introduction followed by rapid, extensive, and continued spread characterized the onset of the epidemic.Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis.The role of ganciclovir for the management of cytomegalovirus retinitis in HIV patients: Pharmacological review and update on new developments.Long-term outpatient treatment of CMV retinitis with ganciclovir in AIDS patients.Clinically resistant cytomegalovirus retinitis.Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression.Toxicity trial of prophylactic 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine (ganciclovir) after marrow transplantation in dogs9-(1-3-Dihydroxy-2-propoxymethyl)guanine prevents death but not immunity in murine cytomegalovirus-infected normal and immunosuppressed BALB/c mice.Antiviral therapy: current concepts and practicesThe history of cytomegalovirus and its diseases.Rapid detection of cytomegalovirus by fluorescent monoclonal antibody staining and in situ DNA hybridization in a dram vial cell culture systemValganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.Cytomegalovirus infection after organ transplantation: an update with special emphasis on renal transplantation.Ganciclovir--a review of pharmacology, therapeutic efficacy and potential use for treatment of congenital cytomegalovirus infections.Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS).Foscarnet as treatment for cytomegalovirus retinitis following bone marrow transplantation.Long term therapy of cytomegalovirus retinitis with ganciclovir in a child with acquired immunodeficiency syndrome.Ophthalmology: ocular manifestations of the acquired immunodeficiency syndrome."The end of innocence" revisited: resistance of herpesviruses to antiviral drugs.Cytomegalovirus colitis and oesophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate).Ocular complications of the acquired immunodeficiency syndrome. Focus on the treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.Chemotherapy of herpesvirus infections: present successes and future hopes.Treatment of cytomegalovirus retinitis: A growing number of options.Ophthalmic findings in a group of ambulatory patients infected by human immunodeficiency virus (HIV): a prospective study.Treatment of cytomegalovirus retinitis with zidovudine and ganciclovir in patients with AIDS: outcome and toxicity.Evaluation by immune scanning electron microscopy of foscarnet treatment of cytomegalovirus infection in patients with renal transplants.Anti-herpes simplex virus (HSV) effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG) in rabbit cornea.Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis.Pharyngeal ulceration in AIDS patients secondary to cytomegalovirus infection.
P2860
Q24628878-FD9E38FF-3F7C-44DC-85DE-01DFCE9EE4D2Q28359800-7754AF94-DAD2-4289-8C68-76AA5CE3442FQ28359826-D0B81649-0648-45BD-BFF3-F21F8E83965CQ28359848-8B4AD7D4-4B14-4C0E-8FFD-E0E871E7CF49Q28360513-4898AB06-0559-4881-8446-6135DBFAB27DQ30047670-8675198F-F44E-44EE-87D0-7128C13550B0Q30368395-10A29AF2-96CA-4CED-B601-E73186545959Q30502919-15B7E82E-AD8D-40CA-A680-66CE1B9F54A5Q33400808-8FA1D8CF-1077-46A9-BCE5-6A232E3897C6Q33419768-34A4E43D-CAB6-4CBE-8418-F9DC53B4CE19Q33569554-0D0DD881-0085-47C5-AC89-1CAD0FD7CB12Q33646478-E7B3F6E0-5D51-45F4-9B22-34D3A6332B55Q35292930-8F65F439-644E-4ED4-ADC5-60B83B0F9FC3Q35540779-E9FE6513-9950-472B-8CD6-DE51A76DC00EQ36070394-10713402-D6FB-45C7-B914-FF3777DF5356Q37035062-27E856F4-9E9F-4273-A6E0-7FDC2FDF3F01Q37150114-23FACDA7-6696-4D6B-AB58-775D004A7AE5Q37570464-87F6B2D1-417B-43C2-BA7B-A4B6FA74AA6AQ38296461-59E24782-ACD1-4B57-8706-FE648E44C5A6Q38305554-1FCDD789-FA1D-4B11-8DC0-AC5C0D0DE7E6Q39139149-C67C6F05-0D8E-4778-AEF8-F65C09BDB526Q39179311-00EC963C-BA67-46D0-BBF2-B1DC505F0B45Q40142484-A250523A-253F-49BC-AD52-87617CEF9AB1Q40367668-D60510DF-D0B2-46E8-B8CF-6A7E36526221Q40720231-516A6FD3-7E31-426F-8C3E-783095CB1AE6Q40798513-BBFC87E9-7CFD-44A8-8A87-337EB25DB7F5Q40853845-50289566-4DC2-4EE4-9389-1A5E98535BDBQ41374911-7E464D93-AA2D-4BC9-8F66-1EE02CC7BEE9Q42544513-A1A26E1B-31CC-4D19-A283-FE84B564A1A3Q42616009-F820D333-489C-4A4D-8029-BEB08C810C38Q42946793-DEE20DE2-BF78-437E-BA07-0C6A9F2528DDQ44662429-5F1438E4-C120-4206-B610-F98B99F41070Q45835133-F244E888-FB9B-41FB-BF88-02D6E875F35BQ46215269-5FE0F24D-F225-4BBB-96E4-77B6CC6E9960Q46838230-A6556833-C2D0-471A-A107-A49C1C1028FF
P2860
Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh-hant
name
Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-
@nl
Treatment of cytomegalovirus r ...... xymethyl)ethoxymethyl]guanine.
@en
type
label
Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-
@nl
Treatment of cytomegalovirus r ...... xymethyl)ethoxymethyl]guanine.
@en
prefLabel
Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-
@nl
Treatment of cytomegalovirus r ...... xymethyl)ethoxymethyl]guanine.
@en
P2093
P1476
Treatment of cytomegalovirus r ...... xymethyl)ethoxymethyl]guanine.
@en
P2093
Cederberg DM
D'Amico DJ
Felsenstein D
Neumeyer DA
Schooley RT
de Miranda P
P304
P356
10.7326/0003-4819-103-3-377
P407
P577
1985-09-01T00:00:00Z